Cognition in acute relapses: A psychometric evaluation and its correlation with event-related potential, P300 in multiple sclerosis

References

• Achiron, A., Chapman, J., Magalashvili, D., Dolev, M., Lavie, M., Bercovich, E., Polliack, M., Doniger, G. M., Stern, Y., Khilkevich, O., Menascu, S., Hararai, G., Gurevich, M., & Barak, Y. (2013). Modeling of cognitive impairment by disease duration in multiple sclerosis: A cross-sectional study. PLOS One, 8(8), e71058. https://doi.org/10.1371/journal.pone.0071058
   PubMed Web of Science ®Google Scholar
• Aksoy, S., Timer, E., Mumcu, S., Akgün, M., Kıvrak, E., & Necioğlu Örken, D. (2013). Screening for cognitive impairment in multiple sclerosis with MOCA test. Turkish Journal of Neurology, 2013(19), 52–55. https://doi.org/10.4274/Tnd.86570
   Google Scholar
• Amato, M., Ponziani, G., Siracusa, G., & Sorbi, S. (2001). Cognitive dysfunction in early-onset multiple sclerosis: A reappraisal after 10 years. Archives of Neurology, 58(10), 1602–1606. https://doi.org/10.1001/archneur.58.10.1602
   PubMed Web of Science ®Google Scholar
• Amato, M., Zipoli, V., & Portaccio, E. (2006). Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies. Journal of the Neurological Sciences, 245(1–2), 41–46. https://doi.org/10.1016/j.jns.2005.08.019
   PubMed Web of Science ®Google Scholar
• Aupperle, R., Beatty, W., Shelton, F. N., & Gontkovsky, N. (2002). Three screening batteries to detect cognitive impairment in multiple sclerosis. Multiple Sclerosis Journal, 8(5), 382–389. https://doi.org/10.1191/1352458502ms832oa
   PubMed Web of Science ®Google Scholar
• Beck, A., Steer, R., & Brown, G. (1996). Beck Depression Inventory – second edition manual. San Antonio.
   Google Scholar
• Benedict, R., DeLuca, J., Phillips, G., LaRocca, N., Hudson, L., Rudick, R., & Consortium, M, S. O. A. (2017). Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis. Multiple Sclerosis, 23(5), 721–733. https://doi.org/10.1177/1352458517690821
   PubMed Web of Science ®Google Scholar
• Benedict, R., Morrow, S., Rodgers, J., Hojnacki, D., Bucello, M., Zivadinov, R., & Weinstock-Guttman, B. (2014). Characterizing cognitive function during relapse in multiple sclerosis. Multiple Sclerosis, 20(13), 1745–1752. https://doi.org/10.1177/1352458514533229.
   PubMed Web of Science ®Google Scholar
• Bergendal, G., Fredrikson, S., & Almkvist, O. (2007). Selective decline in information processing in subgroups of multiple sclerosis: An 8-year longitudinal study. European Neurology, 57(4), 193–202. https://doi.org/10.1159/000099158
   PubMed Web of Science ®Google Scholar
• Cutter, G., Baier, M., Rudick, R., Cookfair, D., Fischer, J., Petkau, J., & Willoughby, E. (1999). Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain, 122(5), 871–882. https://doi.org/10.1093/brain/122.5.871
   PubMed Web of Science ®Google Scholar
• Cutter, G., Baier, M., Rudick, R., Willoughby, D., Fischer, J., Petkau, J., & Willoughby, E. (2001). Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. Archives of Neurology, 58(6), 961–967. https://doi.org/10.1001/archneur.58.6.961
   PubMedGoogle Scholar
• Dagenais, D., Rouleau, I., Demers, M., Jobin, C., Roger, E., Chamelian, L., & Duquette, P. (2013). Value of the MoCA test as a screening instrument in multiple sclerosis. Canadian Journal of Neurological Sciences, 40(3), 410–415. https://doi.org/10.1017/s0317167100014384
   PubMed Web of Science ®Google Scholar
• Filipović, S., Drulović, J., Stojsavljević, N., & Lević, Z. (1997). The effects of high-dose intravenous methylprednisolone on event-related potentials in patients with multiple sclerosis. Journal of the Neurological Sciences, 152(2), 147–153. https://doi.org/10.1016/S0022-510X(97)00159-7
   PubMed Web of Science ®Google Scholar
• Foong, J., Rozewicz, L., Quaghebeur, G., Thompson, A., Miller, D., & Ron, M. (1998). Neuropsychological deficits in multiple sclerosis after acute relapse. Journal of Neurology, Neurosurgery, and Psychiatry, 64(4), 529–532. https://doi.org/10.1136/jnnp.64.4.529
   PubMed Web of Science ®Google Scholar
• Freitas, S., Batista, S., Afonso, A. C., Simões, M. R., de Sousa, L., Cunha, L., & Santana, I. (2018). The Montreal Cognitive Assessment (MoCA) as a screening test for cognitive dysfunction in multiple sclerosis. Applied Neuropsychology: Adult, 25(1), 57–70. https://doi.org/10.1080/23279095.2016.1243108
   PubMed Web of Science ®Google Scholar
• Gagnon, G., Hansen, K., Woolmore-Goodwin, S., Gutmanis, I., Wells, J., Borrie, M., & Fogarty, J. (2013). Correcting the MoCA for education: Effect on sensitivity. Canadian Journal of Neurological Sciences, 40(5), 678–683. https://doi.org/10.1017/s0317167100014918
   PubMed Web of Science ®Google Scholar
• Giedraitiene, N., Kaubrys, G., & Kizlaitiene, R. (2018). Cognition during and after multiple sclerosis relapse as assessed with the Brief International Cognitive Assessment for multiple sclerosis. Scientific Reports, 8(1), 1–8. https://doi.org/10.1038/s41598-018-26449-7
   PubMedGoogle Scholar
• Giesser, B. S., Schroeder, M. M., La Rocca, N. G., Kurtzberg, D., Ritter, W., Vaughan, H. G., & Scheinberg, L. C. (1992). Endogenous event-related potentials as indices of dementia in multiple sclerosis patients. Electroencephalography and Clinical Neurophysiology, 82(5), 320–329. https://doi.org/10.1016/0013-4694(92)90002-y
   PubMedGoogle Scholar
• Gil, R., Zai, L., Neau, J. P., Jonveaux, T., Agbo, C., Rosolacci, T., Burbaud, P., & Ingrand, P. (1993). Event-related auditory evoked potentials and multiple sclerosis. Electroencephalography and Clinical Neurophysiology, 88(3), 182–187. https://doi.org/10.1016/0168-5597(93)90003-8
   PubMedGoogle Scholar
• Idiman, E., Uzunel, F., Ozakbas, S., Yozbatiran, N., Oguz, M., Callioglu, B., Gokce, N., & Bahar, Z. (2006). Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample. Journal of the Neurological Sciences, 240(1–2), 77–80. https://doi.org/10.1016/j.jns.2005.09.009
   PubMed Web of Science ®Google Scholar
• Ivica, N., Titlic, M., & Pavelin, S. (2013). P300 wave changes in patients with multiple sclerosis. Acta Informatica Medica, 21(3), 205–207. https://doi.org/10.5455/aim.2013.21.205-207
   PubMedGoogle Scholar
• Korakas, N., & Tsolaki, M. (2016). Cognitive impairment in multiple sclerosis: A review of neuropsychological assessments. Cognitive and Behavioral Neurology, 29(2), 55–67. https://doi.org/10.1097/WNN.0000000000000097
   PubMed Web of Science ®Google Scholar
• Kujala, P., Portin, R., & Ruutiainen, J. (1997). The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. Brain, 120(2), 289–297. https://doi.org/10.1093/brain/120.2.289
   PubMedGoogle Scholar
• Kurtzke, J. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33(11), 1444–1452. https://doi.org/10.1212/WNL.33.11.1444
   PubMed Web of Science ®Google Scholar
• Magnano, I., Aiello, I., & Piras, M. R. (2006). Cognitive impairment and neurophysiological correlates in MS. Journal of the Neurological Sciences, 245(1–2), 117–122. https://doi.org/10.1016/j.jns.2005.08.027
   PubMed Web of Science ®Google Scholar
• Miller, E., Morel, A., Redlicka, J., Miller, I., & Saluk, J. (2018). Pharmacological and non-pharmacological therapies of cognitive impairment in multiple sclerosis. Current Neuropharmacology, 16(4), 475–483. https://doi.org/10.2174/1570159X15666171109132650
   PubMed Web of Science ®Google Scholar
• Morrow, S., Jurgensen, S., Forrestal, F., Munchauer, F., & Benedict, R. (2011). Effects of acute relapses on neuropsychological status in multiple sclerosis patients. Journal of Neurology, 258(9), 1603–1608. https://doi.org/10.1007/s00415-011-5975-3
   PubMed Web of Science ®Google Scholar
• Nauta, I. M., Speckens, A. E. M., Kessels, R. P. C., Geurts, J. J. G., de Groot, V., Uitdehaag, B. M. J., Fasotti, L., & de Jong, B. A. (2017). Cognitive rehabilitation and mindfulness in multiple sclerosis (REMIND-MS): A study protocol for a randomised controlled trial. BMC Neurology, 17(1), 201–210. https://doi.org/10.1186/s12883-017-0979-y
   PubMedGoogle Scholar
• Ozakbas, S., Cagiran, I., Ormeci, B., & Idiman, E. (2004). Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. Journal of the Neurological Sciences, 218(1–2), 3–7. https://doi.org/10.1016/j.jns.2003.09.015
   PubMed Web of Science ®Google Scholar
• Ozakbas, S., Turkoglu, R., Tamam, Y., Terzi, M., Taskapilioglu, O., Yucesan, C., Baser, H. L., Gencer, M., Akil, E., Sen, S., Turan, O. F., Sorgun, M. H., Yigit, P., & Turkes, N. (2018). Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial. Multiple Sclerosis and Related Disorders, 22, 70–76. https://doi.org/10.1016/j.msard.2018.03.009
   PubMed Web of Science ®Google Scholar
• Pardini, M., Uccelli, A., Grafman, J., Yaldizli, Ö., Mancardi, G., & Roccatagliata, L. (2014). Isolated cognitive relapses in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 85(9), 1035–1037. https://doi.org/10.1136/jnnp-2013-307275
   PubMed Web of Science ®Google Scholar
• Potagas, C., Giogkaraki, E., Koutsis, G., Mandellos, D., Tsirempolou, E., Sfagos, C., & Vassilopoulos, D. (2008). Cognitive impairment in different MS subtypes and clinically isolated syndromes. Journal of the Neurological Sciences, 267(1–2), 100–106. https://doi.org/10.1016/j.jns.2007.10.002
   PubMed Web of Science ®Google Scholar
• Rao, S. (1990). A manual for the Brief Repeatable Battery of neuropsychological tests in multiple sclerosis. Cognitive Function Study Group of the National Multiple Sclerosis Society, National Multiple Sclerosis Society.
   Google Scholar
• Ruano, L., Portaccio, E., Goretti, B., Niccolai, C., Severo, M., Patti, F., Cilia, S., Gallo, P., Grossi, P., Ghezzi, A., Roscio, M., Mattioli, F., Stampatori, C., Trojano, M., Viterbo, R. G., & Amato, M. P. (2017). Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Multiple Sclerosis, 23(9), 1258–1267. https://doi.org/10.1177/1352458516674367
   PubMed Web of Science ®Google Scholar
• Ruggieri, R., Palermo, R., Vitello, G., Gennuso, M., Settipani, N., & Piccoli, F. (2003). Cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis with EDSS < or = 3.5. Acta Neurologica Scandinavica, 108(5), 323–326. https://doi.org/10.1034/j.1600-0404.2003.00157.x
   PubMed Web of Science ®Google Scholar
• Selekler, K. (2010). Power of discrimination of Montreal Conitive Assessment (MOCA) Scale in Turkish patients with mild cognitive impairment and Alzheimer’s disease. Turkish Journal of Geriatrics, 13(3), 166–171.
   Google Scholar
• Sepulcre, J., Vanotti, S., Hernández, R., Sandoval, G., Cáceres, F., Garcea, O., & Villoslada, P. (2006). Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test. Multiple Sclerosis, 12(2), 187–195. https://doi.org/10.1191/1352458506ms1258oa
   PubMed Web of Science ®Google Scholar
• Sumowski, J. F., Benedict, R., Enzinger, C., Filippi, M., Geurts, J. J., Hamalainen, P., Hulst, H., Inglese, M., Leavitt, V. M., Rocca, M. A., Rosti-Otajarvi, E. M., & Rao, S. (2018). Cognition in multiple sclerosis: State of the field and priorities for the future. Neurology, 90(6), 278–288. https://doi.org/10.1212/WNL.0000000000004977
   PubMed Web of Science ®Google Scholar
• Sundgren, M., Nikulin, V. V., Maurex, L., Wahlin, Å., Piehl, F., & Brismar, T. (2015). P300 amplitude and response speed relate to preserved cognitive function in relapsing–remitting multiple sclerosis. Clinical Neurophysiology, 126(4), 689–697. https://doi.org/10.1016/j.clinph.2014.07.024
   PubMed Web of Science ®Google Scholar
• Tourtellotte, W., Syndulko, K., & Jennings, P. (1984). Use of P300 and a dementia rating scale in the evaluation of cognitive dysfunction in MS. Acta Neurologica Scandinavica, 101(101 S), 32–34. https://doi.org/10.1111/j.1600-0404.1984.tb02548.x
   Google Scholar
• Triantafyllou, N., Voumvourakis, K., Zalonis, I., Sfagos, K., Mantouvalos, V., Malliara, S., & Papageorgiou, C. (1992). Cognition in relapsing-remitting multiple sclerosis: A multichannel event-related potential (P300) study. Acta Neurologica Scandinavica, 85(1), 10–13. https://doi.org/10.1111/j.1600-0404.1992.tb03988.x
   PubMed Web of Science ®Google Scholar
• Zwecker, M., Sarova, I., Lavie, M., Zeilig, G., & Achiron, A. (2018). Detection of cognitive impairment in multiple sclerosis based on P300 event-related potential. International Journal of Physical Medicine & Rehabilitation. https://doi.org/10.4172/2329-9096.1000479
   Google Scholar